Formic Acid

Formic Acid

SCHEMBL4665776

CN1CCC(CCOc2ccc(-c3cc(Nc4ccc(NS(=O)(=O)c5ccc(F)cc5F)cc4)ncn3)cc2)CC1.O=CO

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 12/20 0.43
BCR P11274 12/20 0.43
PIK3R1 P27986 2/20 0.41
PIK3CA P42336 2/20 0.41
PRF1 P14222 1/20 0.37
PIK3C3 Q8NEB9 2/20 0.37
SGK1 O00141 1/20 0.37
MEN1 O00255 1/20 0.37
USP2 O75604 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
GLA P06280 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL4665767 0.93 PIK3R1 (0.47) ABL1BCRPIK3R1PIK3CAPIK3C3
Formic Acid SCHEMBL4667491 0.92 ABL1 (0.44) ABL1BCRSGK1
Formic Acid SCHEMBL4665892 0.92 PIK3CA (0.42) ABL1BCRPIK3R1PIK3CAPRF1
Formic Acid SCHEMBL4667429 0.89 ABL1 (0.45) ABL1BCRPIK3R1PIK3CAMEN1
SCHEMBL4666108 0.89 PIK3R1 (0.49) ABL1BCRPIK3R1PIK3CAPIK3C3
Formic Acid SCHEMBL4667407 0.89 ABL1 (0.44) ABL1BCR
Formic Acid SCHEMBL4664246 0.89 AXL (0.47) ABL1BCRPIK3R1PIK3CA
Formic Acid SCHEMBL4664348 0.86 ABL1 (0.42) ABL1BCRPIK3R1PIK3CA
Formic Acid SCHEMBL4665809 0.86 HRH3 (0.45) ABL1BCRPIK3R1PIK3CACYP3A4
Formic Acid SCHEMBL4667479 0.86 PIK3R1 (0.49) ABL1BCRPIK3R1PIK3CAPIK3C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242681-A1 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors ALTANA PHARMA AG (DE) 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242681-A1 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors MAP3K19, MAP3K6, MAP3K20 ABL1 24/4885BCR 402/4885PIK3R1 385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.